Treatment Review
Already have a medical decision? Get a second clinical perspective.
Bring your diagnosis, treatment plan, medications, records and labs. The Clinical Council reviews them together — and gives you one structured conclusion.
What You Bring
Whatever the case contains
You don't need a perfectly organized record. Bring what you have — the Council works with real cases, and missing information becomes part of the review.
- Diagnosis
- Treatment plan
- Medication list
- Relevant records
- Labs
- Supporting documentation
The Review
What the Council looks at
01
Reasoning
Does the logic of the plan follow from the findings in the case?
02
Available evidence
How the plan sits against relevant clinical evidence and guidance.
03
Consistency with findings
Whether labs, imaging and history support the current direction.
04
Alternative considerations
Other explanations or approaches the evidence leaves open.
05
Medication issues
Interactions, duplication, timing, side-effect patterns and DNA considerations.
06
Missing information
What isn't in the case — and how much it would change the picture.
07
Questions worth discussing
A short, specific list to bring to your physician.
Sample Council
This is what a conclusion looks like
A real Council report from a fictional sample case — conclusion first, reasoning and evidence when you want to go deeper.
Council Report — Michael R., 54
Sample
The current treatment direction is broadly consistent with the evidence and the recorded findings. Three points deserve attention before the next visit: the ALT trend after the statin dose change, the unexplained persistent fatigue, and two missing data points that would sharpen the picture.
Findings the Council agreed matter most, ordered by how much they change the interpretation of the case.
- ALT rose after the atorvastatin dose increase — timing supports a review
- HbA1c improved steadily over 17 months
- Fatigue remains without a documented workup
Elements of the diagnosis and treatment plan that are well supported by the records, labs and history in this case — including the blood-pressure control strategy and the overall diabetes management direction.
The fatigue complaint has persisted across four visits without a clear explanation in the record. It does not contradict the current diagnoses, but it is not explained by them either — which keeps it on the Council's list.
Findings that surface when the whole case is reviewed together and may be worth another look.
- Iron status near the low end of the range alongside ongoing fatigue
- No repeat liver panel after the ALT increase
The three current medications were reviewed for interactions, duplication, timing and fit with the rest of the case. No direct drug–drug conflicts found. One medication-related consideration — the statin and the ALT trend — is carried into the conclusion.
The uploaded PGx profile shows a CYP2C19 reduced-function result with no strong conflict against current medications, and normal SLCO1B1 function relevant to statin tolerance. The profile stays attached to the case for future medication decisions.
Information that does not appear in the case and would materially improve the review.
- Repeat liver panel
- Ferritin and B12 results
- Most recent blood-pressure readings from home
A short, ordered list of practical next steps to discuss with a qualified healthcare professional — starting with the repeat liver panel and the fatigue workup.
Each conclusion links back to the parts of the case it rests on — specific lab values, dates, medication changes and relevant clinical guidance — so the reasoning can be inspected rather than taken on trust.
A concise list the report prepares automatically.
- Should the ALT be rechecked before the next statin refill?
- Does the fatigue warrant ferritin and B12 testing?
- Is the current statin intensity still the right target?
Ready for a second clinical perspective?
Diagnosis. Treatment. Medications. Labs. DNA. History. Reviewed together.